Answers are grounded in this paper and cite their sources.
Alzheimer’s disease (AD) is a widespread neurodegenerative disorder characterized by the formation of beta-amyloid oligomers and aggregates in brain tissue, neuronal death, and progressive cognitive dysfunction. Neuroinflammation mediated by microglial cells, which are activated by β-amyloid, plays a key role in neurodegeneration in AD. Currently, increasing evidence is emerging on the ability of specific Na,K-ATPase ligands, cardiotonic steroids (CTS), to suppress neuroinflammation. This study assessed the effects of two types of CTS—bufadienolides (bufalin and marinobufagenin) and cardenolides (digoxin and ouabain)—on the characteristics of human HMC3 microglial cells in the presence or absence of β-amyloid. In the presence of β-amyloid, microglial activation was previously shown to occur, accompanied by a change in their redox status and phagocytosis of β-amyloid. Using flow cytometry and fluorescence microscopy, we assessed the proportion of dead cells in the population, cell granularity, lysosome content, mitochondrial potential, relative levels of glutathione, nitric oxide, and the production of various reactive oxygen species (ROS). It was found that subnanomolar concentrations of CTS did not reduce the increased granularity or lysosome count, nor did they prevent cell death in response to β-amyloid. Ouabain reduced the mitochondrial potential increased by β-amyloid, while bufalin and digoxin reduced ROS production, and bufalin also reduced glutathione levels, which increased due to microglial activation. Increased ROS production in microglial cells was shown to be primarily due to an increase in mitochondrial superoxide anion radical production, and this effect was suppressed by bufalin. Thus, CTS normalize redox parameters altered by β-amyloid activation of microglia.
No takes yet. Share an insight, caveat, or question.
Barkovskaya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: